Relation between urine zinc and hydroxyproline in rheumatoid arthritis and bone diseases
Ambanelli, U.; Ferraccioli, G.F.; Bernardi, P.; Servemti, G.
Journal of Rheumatology 5(4): 477-479
1978
ISSN/ISBN: 0315-162X PMID: 739496 Document Number: 131912
Document emailed within 1 workday
Related Documents
Milanino, R.; Frigo, A.; Bambara, L.M.; Marrella, M.; Moretti, U.; Pasqualicchio, M.; Biasi, D.; Gasperini, R.; Mainenti, L.; Velo, G.P. 1993: Copper and zinc status in rheumatoid arthritis: studies of plasma, erythrocytes, and urine, and their relationship to disease activity markers and pharmacological treatment Clinical and Experimental Rheumatology 11(3): 271-281Sahin, G.; Guler, H.; Incel, N.; Sezgin, M.; As, I. 2006: Soft tissue composition, axial bone mineral density, and grip strength in postmenopausal Turkish women with early rheumatoid arthritis: Is lean body mass a predictor of bone mineral density in rheumatoid arthritis? International Journal of Fertility and Women's Medicine 51(2): 70-74
Marhoffer, W.; Schatz, H.; Stracke, H.; Ullmann, J.; Schmidt, K.; Federlin, K. 1991: Serum osteocalcin levels in rheumatoid arthritis: a marker for accelerated bone turnover in late onset rheumatoid arthritis Journal of Rheumatology 18(8): 1158-1162
Rosano, C.L.; Parhami, N.; Hurwitz, C. 1979: The clinical significance of protein-bound hydroxyproline fractions in sera of patients with adult rheumatoid arthritis Journal of Rheumatology 6(6): 656-663
Suka, M.; Kiyota, A.; Yoshida, K. 2003: Development of disease burden score concerning bone and joint diseases: comparison between rheumatoid arthritis and osteoarthritis Ryumachi 43(1): 29-38
Vischer, T.L.; Jeannet, M. 1986: Lymphocytotoxic antibodies in rheumatoid arthritis: relation to HLA-DR2 and rheumatoid factors Clinical and Experimental Rheumatology 4(2): 139-142
Román, H. 1980: Oral zinc therapy in juvenile rheumatoid arthritis Orvosi Hetilap 121(23): 1390-1392
Adebajo, A.O.; Cawston, T.E.; Hazleman, B.L. 1994: Rheumatoid factors in association with rheumatoid arthritis and infectious diseases in West Africans Journal of Rheumatology 21(5): 968-969
Liu, S.; Li, Y.; Xia, L.; Shen, H.; Lu, J. 2019: IL-35 prevent bone loss through promotion of bone formation and angiogenesis in rheumatoid arthritis Clinical and Experimental Rheumatology 37(5): 820-825
Macovei, L.; Ancuţa, C.; Pomîrleanu, C.; Chirieac, R. 2012: Identification of bone mass and bone turnover in patients with rheumatoid arthritis treated with corticosteroids in order to elaborate an optimal therapeutic approach Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 116(2): 470-476
Hrncír, Z.; Tichý, M.; Chobola, M.; Herout, V. 1976: M component and monoclonal lambda light chains in the urine during screening for amyloidosis of the kidney in rheumatoid arthritis Vnitrni Lekarstvi 22(1): 84-89
Lange, U.; Boss, B.; Teichmann, J.; Stracke, H.; Neeck, G. 2000: Bone mineral density and biochemical markers of bone metabolism in late onset rheumatoid arthritis and polymyalgia rheumatica--a prospective study on the influence of glucocorticoid therapy Zeitschrift für Rheumatologie 59(Suppl 2): Ii/137-Ii/141
van Saase, J.; Vandenbroucke, J.; Valkenburg, H.; Boersma, J.; Cats, A.; Festen, J.; Hartman, A.; Huber-Bruning, O.; Rasker, J.; Weber, J. 1987: Changing pattern of drug use in relation to disease duration of rheumatoid arthritis Journal of Rheumatology 14(3): 476-478
Goldstein, R.; Duff, S.; Karsh, J. 1987: Functional assessment and symptoms of rheumatoid arthritis in relation to menstrual cycle phase Journal of Rheumatology 14(2): 395-397
Alstergren, P.; Ernberg, M.; Kopp, S.; Lundeberg, T.; Theodorsson, E. 1999: TMJ pain in relation to circulating neuropeptide Y, serotonin, and interleukin-1 beta in rheumatoid arthritis Journal of Orofacial Pain 13(1): 49-55
Kaufmann, Jörg.; Kielstein, V.; Kilian, S.; Stein, Günter.; Hein, G. 2003: Relation between body mass index and radiological progression in patients with rheumatoid arthritis Journal of Rheumatology 30(11): 2350-2355
Al-Awadhi, A.M.; Olusi, S.O.; al-Zaid, N.S.; Prabha, K.; al-Jarallah, K.H.; Ahmed, A.H.; al-Salem, I.; Sedeqi, H.; Atteyah, Y. 1998: Urine levels of type 1 collagen cross-linked N-telopeptides and deoxypyridinoline correlate with disease activity in rheumatoid arthritis Clinical and Experimental Rheumatology 16(5): 569-572
Magyar, E.; Talerman, A.; Fehér, M.; Wouters, H.W. 1974: Giant bone cysts in rheumatoid arthritis Journal of Bone and Joint Surgery. British Volume 56(1): 121-129
Moens, H.J.; Ament, B.J.; Feltkamp, B.W.; van der Korst, J.K. 1987: Longterm followup of treatment with D-penicillamine for rheumatoid arthritis: effectivity and toxicity in relation to HLA antigens Journal of Rheumatology 14(6): 1115-1119
Brun, J.G.; Haga, H.J.; Bøe, E.; Kallay, I.; Lekven, C.; Berntzen, H.B.; Fagerhol, M.K. 1992: Calprotectin in patients with rheumatoid arthritis: relation to clinical and laboratory variables of disease activity Journal of Rheumatology 19(6): 859-862